2022
DOI: 10.3390/ijerph19063481
|View full text |Cite
|
Sign up to set email alerts
|

Differences in Outpatient Health Care Utilization 12 Months after COVID-19 Infection by Race/Ethnicity and Community Social Vulnerability

Abstract: Ensuring access to high-quality outpatient care is an important strategy to improve COVID-19 outcomes, reduce social inequities, and prevent potentially expensive complications of disease. This study assesses the equity of health care response to COVID-19 by examining outpatient care utilization by factors at the individual and community levels in the 12 months prior to and following COVID-19 diagnosis. Employing a retrospective, observational cohort design, we analyzed electronic health record data from a sam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 42 publications
0
7
0
Order By: Relevance
“…Consequently, attempts at elucidating how multimorbidity is occurring have been heavily constrained by the lack of integrated technologies and opportunities for data aggregation that exists within the domain of biomedical informatics. [13][14][15][16][17][18][19][20][21][22][23][24][25] Examining the capacities of the learning health systems (LHS) and processes in which multimorbidity data are collected and managed has not been prioritized, [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] leaving much of what is known about multimorbidity to focus on simply revealing patterns of chronic conditions among elderly patients (i.e., ages ≥65). Therefore, the aim of this study was to 1) characterize patterns of multimorbidity across patients, more broadly, among all demographic groups (i.e., age, gender, race, and ethnicity) and 2) concurrently, identify opportunities to strengthen the informatics capacity (i.e., technologies, data, and processes) of a learning health system, using the Arkansas Clinical Data Repository as a use case.…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, attempts at elucidating how multimorbidity is occurring have been heavily constrained by the lack of integrated technologies and opportunities for data aggregation that exists within the domain of biomedical informatics. [13][14][15][16][17][18][19][20][21][22][23][24][25] Examining the capacities of the learning health systems (LHS) and processes in which multimorbidity data are collected and managed has not been prioritized, [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] leaving much of what is known about multimorbidity to focus on simply revealing patterns of chronic conditions among elderly patients (i.e., ages ≥65). Therefore, the aim of this study was to 1) characterize patterns of multimorbidity across patients, more broadly, among all demographic groups (i.e., age, gender, race, and ethnicity) and 2) concurrently, identify opportunities to strengthen the informatics capacity (i.e., technologies, data, and processes) of a learning health system, using the Arkansas Clinical Data Repository as a use case.…”
Section: Introductionmentioning
confidence: 99%
“…Our results are consistent with previous findings identifying specific subgroups as more vulnerable to both acute-COVID ( 38 ) and several symptoms of long-COVID ( 39 41 ). Additionally, recent evidence indicates higher rates of healthcare utilization (e.g., visits with a primary care provider) in the year following the acute COVID infection among socially vulnerable populations ( 42 ), highlighting the potential burden on healthcare facilities and staff among marginalized communities. Notably, in the current analysis, individuals from the high-income group that experienced mild or severe acute-COVID symptomatology also reported relatively high rates of long-term symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…For example, COVID-19 related mortality experienced among racial/ethnic minority adults was 1.9–2.4 times greater than non-Hispanic adults (Badalov et al, 2022). Estimates also show a disproportionate burden of COVID-19 infection (Adhikari et al, 2020; Kimani et al, 2021) and hospitalizations (Karaca-Mandic et al, 2021; Roth et al, 2022) experienced by racial/ethnic adults. Even as the U.S. federal government has rescinded the COVID-19 national public health emergency, non-Hispanic Black and Latinx adults are still grappling with the consequences of elevated COVID-19 transmission/infection and mortality inequities at the height of the pandemic.…”
Section: Introductionmentioning
confidence: 99%